SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001140361-18-013695
Filing Date
2018-03-15
Accepted
2018-03-15 17:17:55
Documents
67
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K h10051697x1_10k.htm 10-K 2488435
2 EXHIBIT 23.1 h10051697x1_ex23-1.htm EX-23.1 3201
3 EXHIBIT 31.1 h10051697x1_ex31-1.htm EX-31.1 16634
4 EXHIBIT 31.2 h10051697x1_ex31-2.htm EX-31.2 16616
5 EXHIBIT 32.1 h10051697x1_ex32-1.htm EX-32.1 10630
12 h10051697x1_linechart1.jpg GRAPHIC 210726
  Complete submission text file 0001140361-18-013695.txt   9014784

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ast-20171231.xml EX-101.INS 1298390
7 XBRL TAXONOMY EXTENSION SCHEMA ast-20171231.xsd EX-101.SCH 69965
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ast-20171231_cal.xml EX-101.CAL 78740
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ast-20171231_def.xml EX-101.DEF 339059
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ast-20171231_lab.xml EX-101.LAB 1011870
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ast-20171231_pre.xml EX-101.PRE 542707
Mailing Address 6300 DUMBARTON CIRCLE FREMONT CA 94555
Business Address 6300 DUMBARTON CIRCLE FREMONT CA 94555 510-456-3805
Asterias Biotherapeutics, Inc. (Filer) CIK: 0001572552 (see all company filings)

IRS No.: 461047971 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36646 | Film No.: 18693351
SIC: 2836 Biological Products, (No Diagnostic Substances)